Replies to post #402243 on Anavex Life Sciences Corp (AVXL)

[bas2020]

Yes, the market has spoken and the whole sector (XBI) sold down today. Such silly conjecture!

[peeved]

Fritzy’s post is accurate

The company needs to be accountable to the shareholders. Clearly missling only cares about scientists. It could take 30 years to get where we need to because he will just dilute without any regard to shareholders.


But fear not he will give himself enough options to prevent his own dilution

[georgejjl]

This is just NOT TRUE!!!

This is just a distraction and an attempt to spread FEAR, UNCERTAINTY and DOUBT into the hearts and minds of shareholders of AVXL.

GOD bless,

[Hoskuld]

The market said nothing about AVXL today - it just followed the XBI as is often the case.

[ExtremelyBullishZig]

Lol...welcome. Now you see what all my posts are about...

[Kb1123]

I share your sentiment. After years of holding on to my shares I long for the day when we see $15+ again so I can sell the majority and hold onto a few thousand shares to see what happens. Too many red flags and procrastination.

[Gator328]

The market would have dropped the stock no matter who financed the deal. Anytime there is a possibility of dilution, some people will panic and sell their shares and it provides an opportunity for others to take short positions.

Dr. Missling made it clear that there is currently 4 years of cash runway available. He's planning for the future to ensure he always has access to cash. What's so bad about that? The deal itself seems favorable and on par with Cantor Fitzgerald's.

Let me ask the board this question: if a blue chip investment bank offered the same $150mm financing, but at worse terms than LPC, which would you prefer Dr. Missling choose? Money is money, and fortunately this money isn't even needed right now. But Dr. Missling is in a far better position to negotiate a deal now with $140mm cash in the bank than he would be when the cash starts to dry up. If anyone wants to know how toxic death spiral financing works, it usually begins with a company that is strapped for cash making disadvantageous, highly-dilutive deals with vulture firms out of necessity. I applaud Dr. Missling for not letting Anavex get to that point.

Maybe the naysayers are correct. The drug is a bust, the FDA is corrupt, whatever the case may be, it's important to always leave some room for doubt. And if one is so easily talked into all the reasons to walk away now, Anavex probably is too high-risk or that person has too much invested. As a purely speculative, high-risk/high-reward gamble, however, I don't know of too many opportunities that are better than what we're facing today.

Much of the risk has evaporated over the last few years. Those attacking the science are slowly changing their tune to attack Dr. Missling because he's an easier target -- at some point the FDA will decide whether the science is valid but CEO criticisms are subjective and can last forever.

What happens if we reach March 1 and nothing happens? Nothing happens. What's so special about March 1 and who cares if the wolves begin to howl? Anavex doesn't have any debt due on March 1, it's just another day.